Medical Oncologist
Deciding on chemotherapy
Can you use a genomic test after chemotherapy has started?
Rarely. The test answers one question: whether to have chemotherapy at all. Once the first cycle has gone in, that question has been answered in practice. This page explains the one situation where a result can still matter, and sets out the questions that are far more useful if what you really want is to stop or to make treatment bearable.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Can a genomic test still help once chemotherapy has started?
- Words that come up in this conversation
- What to ask instead, if you are struggling
- When the test helps, and when it does not
- If you are thinking about stopping
- What people believe about testing mid-treatment
- Common questions about testing mid-treatment
The short answer
Can a genomic test still help once chemotherapy has started?
Rarely. The test exists to answer one question: should you have chemotherapy at all. Once the first cycle has gone in, that question has been answered in practice, and a score arriving afterwards has very little left to change.
Why the timing matters so much
The score predicts what a full course of chemotherapy would add on top of hormone tablets. It was never designed to answer whether to continue a course already underway, and there is no good evidence telling anyone how to use it that way.
The one situation where it can still matter
If you are early in the course and genuinely considering stopping, the result can inform that conversation. Even then it is a judgement made with your oncologist rather than a clean answer, and it needs to happen quickly.
Do not stop treatment while waiting for a result. Talk to your oncologist first.The vocabulary
Words that come up in this conversation
- Adjuvant chemotherapy
- Chemotherapy given after surgery to lower the chance of the cancer returning. This is what the score speaks to.
- Neoadjuvant chemotherapy
- Chemotherapy given before surgery. Here the tissue used for testing would be the original biopsy rather than the surgical specimen.
- Dose reduction
- Lowering the dose because of side effects. A separate decision from stopping, and one your oncologist makes routinely.
- Completing the course
- Finishing the planned number of cycles. Stopping part way generally gives less benefit than completing, though not none.
- Endocrine therapy
- Hormone tablets or injections. These continue for years after chemotherapy and do a great deal of the long-term work.
Better questions
What to ask instead, if you are struggling
Most people asking about a test part way through are really asking whether they can stop. That is a better conversation to have directly.
Can the dose be reduced?
Cutting the dose is a routine adjustment and often keeps you on treatment when you were ready to give up. Ask before you decide to stop, not afterwards.
Can the drugs be changed?
Where one particular side effect is the problem, a different drug in the plan sometimes solves it. Numbness in the hands and feet is a common reason for this kind of change.
Report numbness early, not at the end.How much do the remaining cycles add?
A fair question and one your oncologist can answer. Sometimes most of the benefit sits in the cycles already given, and sometimes it does not. Ask which applies to your plan.
Is the supportive treatment right?
Sickness, mouth soreness and exhaustion are often undertreated rather than unavoidable. Before deciding the treatment is intolerable, make sure everything available has been tried.
Worth reviewing
- Anti-sickness medicines
- Mouth care and pain relief
- Blood count support
Not sure whether this applies to you?
Ask an oncologistTalk to our team
Have a question about your situation?
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Side by side
When the test helps, and when it does not
Point in your treatment
What the test can still do
After surgery, before the first cycle
Everything. This is the window it was designed for
After one cycle, seriously considering stopping
It can inform the conversation, imperfectly and urgently
Half way through the planned course
Very little. Most of the decision has been made
Chemotherapy finished
Nothing for this decision. Turn to the hormone plan instead
Cancer has come back or spread
Nothing. Different tests apply in that situation
Being straight with you
If you are thinking about stopping
Wanting to stop part way through chemotherapy is common and it is not a failure of will. Say it out loud to your oncologist rather than simply not turning up, because almost everything that makes treatment bearable is on the other side of that conversation.
Stopping is not all or nothing
Between finishing the full course and abandoning it there are dose reductions, drug substitutions, longer gaps and better supportive medicines. Most people who reach the point of wanting to stop can be kept going by one of those.
What a partial course gives you
Completing fewer cycles than planned usually gives less benefit than the full course, and more than none. Your oncologist can tell you roughly where you stand, and that honest figure is more useful for the decision than a genomic score arriving weeks later.
It remains your decision
You are entitled to stop, and your team should continue caring for you if you do. What matters is that the decision is made on real information: what the remaining cycles would add, what can be done about the side effects, and what the plan looks like either way.
Take the family member who is worrying with you
Decisions about stopping are rarely made alone in an Indian family, and pretending otherwise helps nobody. Bring the person who is pressing you hardest to continue, or hardest to stop, into the room. Hearing the honest figures directly from the oncologist settles far more arguments at home than repeating them second hand ever does.
Commonly believed
What people believe about testing mid-treatment
A low score now would prove the chemotherapy was unnecessary.
It would tell you what the expected benefit was for a full course, decided before treatment. It cannot tell you that your treatment was wrong, and hindsight applied to a decision made in good faith on the evidence available rarely helps anyone.
Stopping now means the cycles so far were wasted.
They were not. A partial course usually gives real though reduced benefit. Framing it as all or nothing pushes people into continuing when they cannot, or abandoning treatment when a smaller adjustment would have worked.
If I ask to stop, my team will give up on me.
They will not, and a good team will work hard to find a version you can tolerate. Not turning up without explanation is far worse for your care than saying plainly that you are struggling.
Side effects mean the treatment is working.
They do not measure whether it is working. Some people have severe effects and some have few, and that difference does not track the benefit. Enduring avoidable side effects in silence helps nobody.
Questions we are asked
Common questions about testing mid-treatment
I have had one cycle. Can I still have the test?
Technically yes, because it runs on tissue stored from before treatment. Whether it is useful is a different question. Raise it urgently with your oncologist and ask specifically what the result could still change for you.
Would the result be affected by the chemotherapy?
The test is run on tissue taken before treatment began, so the chemotherapy does not alter the score itself. The problem is not accuracy. It is that the decision the score informs has already been taken.
Can I pause treatment while I wait?
Not without your oncologist's agreement. The spacing of cycles matters, and an unplanned gap can reduce the benefit of the whole course. If you want to pause, say so and agree it properly.
What if I have already finished chemotherapy?
The test will not change what has been given. What is still open is how long you stay on hormone treatment and how closely you are followed. Put your questions there, because those decisions are still in front of you.
Is it worth paying for now, for peace of mind?
Usually not. A score that cannot change your treatment often adds worry rather than removing it, particularly if it comes back high. Ask your oncologist what they would do with the result before you pay for it.
My side effects are unbearable. What should I ask for?
Ask about a dose reduction, about changing one of the drugs, about a longer gap between cycles, and about better supportive medicines. One of those solves the problem for most people who reach this point.
Will stopping early ruin my chances?
It generally reduces the benefit rather than removing it, and the hormone tablets that follow still do a great deal of work over the years ahead. Ask your oncologist for an honest estimate of where stopping now would leave you.
Should I get a second opinion instead?
If you doubt the plan rather than simply struggling with it, yes, and quickly, so it does not delay treatment. Take your full pathology report and the details of what you have already received.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Warangal
Vizag
Talk to our team
Speak to a breast cancer specialist
Call the helpline or leave your details, and someone will help you arrange a consultation at the CION centre nearest you. One helpline serves every CION centre.
Call 1800 202 8726
Helpline open 24/7
Sources
- National Cancer Institute — Breast cancer gene expression tests
- Cancer Research UK — Chemotherapy for breast cancer
- Breast Cancer Now — Coping with chemotherapy side effects
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.